Vipergen has developed a proprietary and cutting-edge drug discovery platform called YoctoReactor®Technology. This technology has the potential to revitalize the drug discovery process by providing access to small molecule combinatorial libraries of up to 1012 compounds – a much greater diversity than available by traditional technologies - for the identification of high quality drug leads. It offers an alternative to lengthy, resource-intensive and costly early stage drug development efforts by circumventing high throughput screening and complex lead-optimization efforts.
The concept is derived from nature: The YoctoReactor® employs the principles of molecular evolution and molecular self-assembly to create and manipulate vast chemical libraries. By partnering with Vipergen this chemical space is addressed and drug candidates are identified rapidly by robust cycles of selection, amplification and translation – all in a single test tube.
